E36 (Potassium Citrate Extended-Release 15 mEq (1620 mg))
Pill with imprint E36 is Yellow, Rectangle and has been identified as Potassium Citrate Extended-Release 15 mEq (1620 mg). It is supplied by Eywa Pharma Inc.
Potassium citrate is used in the treatment of nephrolithiasis; renal tubular acidosis and belongs to the drug class urinary pH modifiers. Risk cannot be ruled out during pregnancy. Potassium citrate 15 mEq (1620 mg) is not a controlled substance under the Controlled Substances Act (CSA).
Images for E36
Potassium Citrate Extended-Release
- Imprint
- E36
- Strength
- 15 mEq (1620 mg)
- Color
- Yellow
- Shape
- Rectangle
- Availability
- Prescription only
- Drug Class
- Urinary pH modifiers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eywa Pharma Inc.
- National Drug Code (NDC)
- 71930-0050
Related images for "E36"
More about potassium citrate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (6)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: urinary pH modifiers
Patient resources
- Other brands
- Urocit-K
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.